Depression News and Research

Latest Depression News and Research

Atopic dermatitis found to be highly prevalent among adults in the U.S.

As many as 16.5 million adults in America suffer from a skin disease known as atopic dermatitis, an inflammatory disease that results in red, itchy skin.

30 Oct 2018

Exercise could reduce risk of falling for older adults with AD

Alzheimer's disease is a brain disease that causes changes that kill brain cells. AD is a type of dementia, which causes memory loss and problems with thinking and making decisions.

29 Oct 2018

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment.

29 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

26 Oct 2018

New discovery may unlock development of next-generation sleeping pill

Insomnia is one of the major sleep problems with an estimated prevalence of 10% to 15% in the general population and 30% to 60% in the older population. Moreover, insomnia frequently co-occurs with a wide range of psychiatric disorders, including depression and anorexia.

26 Oct 2018

Innovative supportive care model tackles burdensome symptoms, challenges of dementia

Individuals with dementia often experience burdensome symptoms such as agitation, aggression, anxiety and pain, but have difficulty with comprehension and communication, making it challenging for healthcare providers to provide appropriate treatment.

26 Oct 2018

Active ingredient in magic mushrooms could soon become a depression treatment

The active ingredient in magic mushrooms is psilocybin. Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushroom and is the reason behind the “high” provided by the magic mushrooms. Now, Psilocybin may soon achieve legal status to be used for treatment of difficult to treat depressive illness.

26 Oct 2018

UTA social work professors use NIH grant to find ways for reducing caregiver stress

Two UTA social work professors are using an NIH grant to find ways to reduce stress of families caring for loved ones with Alzheimer's disease.

26 Oct 2018

Good mental ability and grip strength may prevent or delay disability in older adults

As we age, we may develop certain disabilities that make it difficult to walk, climb, balance, or maintain our fine motor skills.

25 Oct 2018

Kent State professor receives NIH grant to study neurological roots of fear memories

People who suffer trauma will, with few exceptions, never forget what happened to them, but a Kent State University researcher may be able to offer them the hope of living without constant fear and anxiety.

25 Oct 2018

Tooth loss linked to malnutrition risk in older adults

Older adults are at risk for both impaired oral health and malnutrition, according to a study by Rutgers University researchers.

25 Oct 2018

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

APA calls on federal government to fund physiotherapy as first line treatment for osteoarthritis

Osteoarthritis is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia’s population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.

25 Oct 2018

Stress can cause memory loss and brain shrinkage finds study

According to a new study persistent stress can cause real damage to the brain. It can cause loss of memory as well as shrinkage of the brain matter say researchers. The results of this new study have been published in the latest issue of the journal Neurology this week.

25 Oct 2018

Men who lack resilience have greater risk for depression

Men who lack resilience are exponentially more vulnerable to becoming severely depressed after their spouse dies, according to a new study from Florida State University researchers.

24 Oct 2018

Stress-induced mental disturbances are directly linked to abnormal glucose metabolism

Chronic stress is a well-known risk factor for the development of psychiatric illnesses including depression disorders. The brain requires a great deal of glucose, and stress is known to alter glucose metabolism.

24 Oct 2018

Family acceptance of LGBT individual's sexuality linked to lower stress

Ohio University Associate Professor of Psychology Dr. Peggy Zoccola has determined that those who identify as LGBT and have come out to their family carry less stress hormones than those who have not come out, which may ultimately benefit their health.

24 Oct 2018

ConnectToBrain project seeks to improve techniques for brain stimulation in current clinical use

The costs associated with neurological diseases amount to 1000 billion euros per year in Europe alone.

23 Oct 2018

Multi-national database can help researchers address questions about bipolar disorder throughout adult lifespan

Not much is known about how bipolar disorder (BD) affects people throughout their lives. Do women and men differ in the severity of their symptoms?

23 Oct 2018

Depression News and Research

Latest Depression News and Research

Atopic dermatitis found to be highly prevalent among adults in the U.S.

Exercise could reduce risk of falling for older adults with AD

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

High-impact clinical trial results could affect kidney-related medical care

New discovery may unlock development of next-generation sleeping pill

Innovative supportive care model tackles burdensome symptoms, challenges of dementia

Active ingredient in magic mushrooms could soon become a depression treatment

UTA social work professors use NIH grant to find ways for reducing caregiver stress

Good mental ability and grip strength may prevent or delay disability in older adults

Kent State professor receives NIH grant to study neurological roots of fear memories

Tooth loss linked to malnutrition risk in older adults

Head and neck cancer survivors more likely to commit suicide

APA calls on federal government to fund physiotherapy as first line treatment for osteoarthritis

Stress can cause memory loss and brain shrinkage finds study

Men who lack resilience have greater risk for depression

Stress-induced mental disturbances are directly linked to abnormal glucose metabolism

Family acceptance of LGBT individual's sexuality linked to lower stress

ConnectToBrain project seeks to improve techniques for brain stimulation in current clinical use

Multi-national database can help researchers address questions about bipolar disorder throughout adult lifespan

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Depression News and Research

Latest Depression News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in